Bristol Myers' Sotyktu, a TYK2 inhibitor already approved for psoriasis, scored a win in a Phase III trial for psoriatic ...

Farther Finance Advisors LLC reduced its RTX holdings by 16.1% in Q1, trimming 8,457 shares but still clinging to 44,067 ...

AMD unveiled its latest AI arsenal, the Instinct MI350 series, touting 4x more compute and a 35x boost in inference. Despite ...

Netflix stock dipped 2.7% after two board members sold a sizable chunk of shares, shaking investor confidence. Director Jay ...

Sagace Wealth Management LLC more than doubled its holdings in Meta Platforms during Q1, snapping up 816 shares valued at ...

Apple plans to roll out an upgraded Siri by spring 2026 as part of iOS 26.4, turning its assistant into something more ...

Berkshire Hathaway, led by investing legend Warren Buffett, holds two dramatically different energy stocks: Occidental ...

Milestone Asset Management slashed its NVIDIA holdings by 21.4% in Q1, reducing its stake to 54,236 shares worth $5.88 ...

T-Mobile CEO Mike Sievert’s rumored early exit sounds less likely when you examine the golden handcuffs in his contract. He ...

Merck’s Animal Health division just fetched a major win as the EU's veterinary committee gave a tail-wagging thumbs-up to ...

Handelsbanken Fonder AB trimmed its QUALCOMM stake by 4.9%, selling over 24,000 shares but still holding $72.9 million worth.

Thermo Fisher is shopping around its microbiology unit, targeting a cool $4 billion from private equity suitors. This move ...